What is QTRX (QTRX) stock price today?

QTRX (QTRX) is currently trading at $2.69, up 4.26% today.

What is QTRX P/E ratio?

QTRX's P/E ratio is -0.98. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is QTRX return on equity (ROE)?

QTRX's return on equity (ROE) is -43.59%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is QTRX's market cap?

QTRX has a market capitalization of $126.72M.

NASDAQ · Medical - Devices

QTRX (QTRX) Stock

$2.69 +4.26% NASDAQ: QTRX Healthcare

Valuation

Metric	Value
Price	$2.69
Market Cap	$126.72M
P/E Ratio	-0.98
P/B Ratio	0.51
P/S Ratio	0.79
EPS (TTM)	$-2.51
52-Week High	$8.77
52-Week Low	$2.15
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-43.59%
ROA	-38.52%
ROCE	-49.08%
Gross Margin	-78.42%
Operating Margin	-79.14%
Net Margin	-80.29%
Debt/Equity	0.14
Current Ratio	2.83

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$111.0M	$106.0M	$121.0M	$135.0M	$139.0M
Operating Profit	$-57.0M	$-104.0M	$-46.0M	$-53.0M	$-110.0M
Net Profit	$-56.0M	$-100.0M	$-28.0M	$-39.0M	$-107.0M
EPS	$-1.60	$-2.61	$-0.86	$-1.00	$-2.51
Op Margin	-51.1%	-98.8%	-38.0%	-38.9%	-79.2%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$507.0M	$434.0M	$429.0M	$407.0M	$419.0M
Total Liabilities	$66.0M	$76.0M	$79.0M	$76.0M	$123.0M
Cash	$396.0M	$339.0M	$174.0M	$57.0M	$30.0M
Borrowings	$22.0M	$44.0M	$41.0M	$37.0M	$37.0M

Latest News

Quanterix Advances Adoption of LucentAD Complete Blood Test MT Newswires · Jul 14, 2026 Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD® Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages Business Wire · Jul 14, 2026 Quanterix (QTRX) Stock Fair Value Falls After Analysts Cut Price Targets Simply Wall St. · Jul 9, 2026 TRIB, QTRX, RCON: Why These Stocks Are Surging After-Hours Today Stocktwits · Jun 24, 2026 Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire · Jun 16, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-48.0M	$-48.0M	$-19.0M	$-35.0M	$-77.0M
Investing Cash Flow	$-20.0M	$-23.0M	$-152.0M	$-86.0M	$48.0M
Financing Cash Flow	$9.0M	$0	$0	$-3.0M	$-1.0M
Net Cash Flow	$216.0M	$-58.0M	$-164.0M	$-118.0M	$-26.0M
Free Cash Flow	$-62.0M	$-60.0M	$-23.0M	$-39.0M	$-80.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.03
EV / EBITDA	-1.03
FCF Yield	-60.87%
Quick Ratio	2.45
Interest Coverage	0.00
Return 1Y	-32.56%
Return 3Y	-82.89%
Return 5Y	-92.21%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
CVRX	$3.05	+1.33%	-1.52	$80.93M	0.00%
IMRX	$4.82	-4.37%	-4.85	$174.98M	0.00%
INGN	$5.42	-0.55%	-5.97	$146.74M	0.00%
MASS	$10.05	+0.10%	-10.80	$412.32M	0.00%
NNOX	$0.83	+16.43%	-0.63	$57.75M	0.00%

About QTRX

QTRX is led by CEO Everett V. Cunningham, publicly traded since 2017.

QTRX stock trades at $2.69 with a market capitalization of $126.72M. The stock is valued at a price-to-earnings (P/E) ratio of -0.98, price-to-book of 0.51, price-to-sales of 0.79. Over the past 52 weeks the stock has ranged between $2.15 and $8.77, and currently trades 69.3% below its 52-week high.

On profitability, QTRX generates a return on equity (ROE) of -43.59%, return on capital employed of -49.08%, an operating margin of -79.14%, a net profit margin of -80.29%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides